A federal jury in Delaware ruled that medical technology manufacturer Life Spine Inc. must pay $9.5 million (approximately RMB 68.24 million) in damages for infringing on a patent held by Globus Medical Inc. for components used in expandable spinal implant devices.

This ruling highlights the ongoing patent litigation landscape within the medical device industry, where companies frequently clash over innovative technologies aimed at improving surgical outcomes.

The disputed patent centers on a complex design used in spinal fusion surgery, a procedure critical for treating spinal conditions. Globus Medical Inc., a major player in the spinal care market, claimed that Life Spine's products infringed on its proprietary technology, leading to significant legal proceedings that culminated in this week's ruling.

Notably, the jury's decision reflects a broader trend in intellectual property disputes, where such cases often involve substantial financial stakes, reflecting the significant technological investments and market potential underlying them.